Lori Taylor

During my 20-year career in the pharmaceutical industry, I have played a crucial role in all stages of a product’s lifecycle, from research through commercialization and growing mature brands. I am passionate about shaping novel products and optimizing their value, particularly if they treat diseases with high unmet needs. I also have a reputation for recruiting and developing world-class teams.

My most notable achievements to date have been spearheading teams that developed and executed lifecycle management plans that boosted Humira to $18B in revenue in 2017, established Tysabri as a brand, and shaped the future portfolio for Vertex. My experience spans multiple business functions, treatment modalities, and therapeutic areas—including applications to oncology, neurology, immunology, gastroenterology, pain, and rare diseases.